ly 293111 has been researched along with cytochrome c-t in 1 studies
| Studies (ly 293111) | Trials (ly 293111) | Recent Studies (post-2010) (ly 293111) | Studies (cytochrome c-t) | Trials (cytochrome c-t) | Recent Studies (post-2010) (cytochrome c-t) |
|---|---|---|---|---|---|
| 38 | 9 | 6 | 11,809 | 21 | 5,125 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adrian, TE; Bell, RH; Ding, XZ; Talamonti, MS; Tong, WG | 1 |
1 other study(ies) available for ly 293111 and cytochrome c-t
| Article | Year |
|---|---|
Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Benzoates; Blotting, Western; Caspase 3; Caspase 7; Caspase 9; Cell Cycle; Cell Line, Tumor; Cyclin A; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cytochromes c; Enzyme Activation; Flow Cytometry; Genes, bcl-2; Humans; Leukotriene Antagonists; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Receptors, Leukotriene B4; S Phase | 2007 |